BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
ERBB2
,
Fatty acid metabolic process
,
Diabetes mellitus
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LILRB1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
Macrophage of peripheral blood
Whole blood
Superior cervical ganglion
Appendix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Contact dermatitis
Acne
Disease due to Rhinovirus
Disease due to Picornaviridae
Drug resistance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Metrizamide
DLL4 protein, human
JM 3100
5-chloro-1-(4-chlorobenzyl)-3-(phenylthio)indole-2-carboxylic acid
Hexamethonium
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR218-1
IKZF3
DLEU1
IRF2
IRAK4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight s…
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferrop…
MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy.
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis.
LILRB4 knockdown inhibits aortic dissection development by regulating pyroptosis and the JAK2/STAT3 …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Infections and Unexplained Infertility
Dose-Escalation and Dose-Expansion Study of IO-202 and IO-202+Pembrolizumab in Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ